Eisai
4523.T
#2013
Rank
S$10.81 B
Marketcap
$38.35
Share price
3.80%
Change (1 day)
-39.54%
Change (1 year)
Eisai is a Japanese pharmaceutical company that is engaged in the R&D of drugs for the treatment of dementia and Alzheimer.

EPS for Eisai (4523.T)

EPS in 2023 (TTM): $2.96

According to Eisai's latest financial reports the company's current EPS (TTM) is $2.95. In 2022 the company made an earnings per share (EPS) of $2.17 a decrease over its 2021 EPS that were of $9.62.

EPS history for Eisai from 2009 to 2023

Annual EPS

Year EPS Change
2023 (TTM)$2.9636.63%
2022$2.17-77.48%
2021$9.62-41.88%
2020$16.55-0.94%
2019$16.7152.59%
2018$10.95124.17%
2017$4.88-49.42%
2016$9.6637.08%
2015$7.04-11.75%
2014$7.98-3.23%
2013$8.25-18.56%
2012$10.13-15.51%
2011$11.99-3.75%
2010$12.46-1.36%
2009$12.63